Dr. Guy Webster, Founding and Current President of the American Acne &
Rosacea Society and Clinical Professor of Dermatology at Jefferson
Medical College stated, "Topical omiganan is a novel approach,
actually the first in a new class of dermatologic drugs, for the
treatment of rosacea. Initial results are promising and I look forward
to a more precise estimation of the effectiveness of the drug in the
larger Phase III program."

source:

http://tinyurl.com/266bj5

Brady
group owner